Hillyer, Christopher D.

Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants

Weisblum, Y., Schmidt, F., Zhang, F., DaSilva, J., Poston, D., Lorenzi, J. C., Muecksch, F., Rutkowska, M., Hoffmann, H.-H., Michailidis, E., et al. (2020) · eLife

SARS-CoV-2 and COVID-19 Researchvaccines and immunoinformatics approaches

Cited by 1,308

Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses

Jiang, S., Hillyer, C., & Du, L. (2020) · Trends in Immunology

SARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections Studies

Cited by 847

A novel receptor-binding domain (RBD)-based mRNA vaccine against SARS-CoV-2

Tai, W., Zhang, X., Drelich, A., Shi, J., Hsu, J. C., Luchsinger, L., Hillyer, C. D., Tseng, C.-T. K., Jiang, S., & Du, L. (2020) · Cell Research

SARS-CoV-2 and COVID-19 ResearchSARS-CoV-2 detection and testing

Cited by 151

The American Red Cross donor hemovigilance program: complications of blood donation reported in 2006

Eder, A. F., Dy, B. A., Kennedy, J. M., Notari IV, E. P., Strupp, A., Wissel, M. E., Reddy, R., Gibble, J., Haimowitz, M. D., Newman, B. H., et al. (2008) · Transfusion

Blood donation and transfusion practicesBlood transfusion and management

Cited by 149

Deubiquitylase USP7 regulates human terminal erythroid differentiation by stabilizing GATA1

Liang, L., Peng, Y., Zhang, J., Zhang, Y., Roy, M., Han, X., Xiao, X., Sun, S., Liu, H., Nie, L., et al. (2019) · Haematologica

Ubiquitin and proteasome pathwaysHemoglobinopathies and Related Disorders

Cited by 37